Introduction
India has emerged as a key player in the global pharmaceutical industry, with a focus on innovation and technology-driven solutions. The country’s pharmaceutical sector is witnessing significant growth, fueled by the establishment of Global Capability Centers (GCCs) in cities like Hyderabad and Bengaluru.
Tech-Driven Drug Discovery
The GCCs in India are leveraging cutting-edge technologies like Gen AI to revolutionize drug discovery processes. These advancements are expected to enhance personalized healthcare delivery and reduce overall healthcare costs.
Renewable Energy Initiatives
Ethanol Blending in Petrol: The Indian government is actively promoting ethanol blending with petrol to support sustainable energy practices. It aims to achieve a 30% ethanol blending target by 2029-30, showcasing India’s commitment to biofuel advancements.
Financial Regulations
Liberalized Remittance Scheme: The Reserve Bank of India’s liberalized remittance scheme allows resident Indians to remit up to $250,000 annually for various purposes, including investments and education. Recent guidelines emphasize the need for proactive utilization of remitted funds within 180 days.
Challenges in Overseas Investments
Repatriation Trend: Resident Indians are facing challenges with overseas investments due to stringent requirements by foreign banks. This has led to a trend of repatriating funds back to India and seeking more accessible investment options.